Dr. Hazel Cheng has over 20 years of experience in clinical development, regulatory leadership, and strategic planning in the biotechnology industry. Prior to joining NKGen Biotech, Dr. Cheng held the position of VP, Clinical and CMC Project Management for AtruBio, Inc., where she led the clinical and regulatory departments supporting a variety of therapeutic areas including oncology/hematology, gastroenterology, rheumatology, and dermatology. Additionally, she served as Vice President of Science and Technology for Westar Nutrition Corp/Viva Life Science where she oversaw regulatory compliance while leading the Quality and R&D departments. Dr. Cheng has co-authored numerous published studies in the fields of oncology, immunology, and hematology. Dr. Cheng holds a BA in Medical Technology and a PhD in Immunology from the College of Medicine, National Taiwan University.